查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
传染病治疗市场，按治疗方式、传染病类型、配销通路、国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测
市场调查报告书
商品编码
1408897

传染病治疗市场，按治疗方式、传染病类型、配销通路、国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测

Infectious Disease Therapeutics Market, By Mode of Treatment, By Infectious Type, By Distribution Channel, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 303 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2022 年传染病治疗市场规模为 680.34 亿美元，2023 年至 2030 年CAGR为 8.2%。

传染病治疗市场-市场动态

预计感染性疾病病例数量的增加将推动市场的成长

传染病病例数量增加，可能会推动对治疗干预措施的需求。这可能是由于生活方式的改变、抗生素抗药性、国际旅行和人口密度等因素造成的。传染病的例子包括流感、麻疹、HIV、链球菌性咽喉炎、COVID-19 和沙门氏菌。虽然传染病在全球普遍存在，但其盛行率各不相同。例如，在美国，每年大约每5个人中就有1人感染流感病毒，而确诊的朊病毒病人数不到300。根据美国国家卫生中心的统计，大约有380万人感染了流感病毒。急诊室就诊，以传染病和寄生虫病作为初步诊断。然而，生物技术和药物研究的不断进步为开发更有效、更有针对性的传染病治疗方法提供了机会。此外，经济衰退和不确定性可能会对医疗保健预算和传染病治疗资金分配产生影响。

传染病治疗市场 - 关键见解

  • 根据我们的研究分析师分享的分析，预计全球传染病治疗市场在预测期内（2023-2030 年）每年将以 8.2% 左右的CAGR成长
  • 根据治疗模式细分，预计药物将在 2022 年显示最大的市场份额
  • 根据感染类型细分，2022年细菌感染为主导类型
  • 从配销通路细分来看，2022年医院为主导类型
  • 按地区划分，北美是 2022 年的主要收入来源

传染病治疗市场-細項分析：

  • 全球传染病治疗市场根据治疗模式、传染病类型、配销通路和地区进行细分。
  • 根据治疗方式，市场分为三类：疫苗和药物。药品领域在市场上占据主导地位。许多全球卫生组织、政府和非政府组织积极致力于促进传染病药物的供应，特别是在这些疾病造成严重公共卫生障碍的地区。
  • 根据感染类型，市场分为两类：病毒、寄生虫、真菌、细菌和其他。细菌细分市场的主导地位在很大程度上影响着市场。细菌感染仍然是一个重大的公共卫生问题，特别是在发展中地区。全球卫生倡议与政府、非营利组织和製药公司之间的合作伙伴关係共同努力，努力提高有效治疗的可用性并减轻全球细菌感染的负担。
  • 根据配销通路，市场分为两类：诊所、医院和其他。医院细分市场占据主导地位。该市场主要由医院部门控制。医院在传染病的识别和治疗中发挥着至关重要的作用。他们拥有诊断设施、实验室和医疗专业人员团队，他们合作确定感染的病原体并建议适当的治疗措施。

传染病治疗市场 - 地理洞察

传染病治疗市场在地理上广泛分布于北美、拉丁美洲、欧洲、亚太地区、中东和非洲等各地区。这些区域根据业务涉及的国家进一步划分。在成长方面，由于抗病毒药物的日益普及以及美国有许多製造商的存在，预计北美将主导市场。美国是医疗保健和製药领域的研发中心，在研发方面的大量投资导致了传染病新治疗药物的发现。根据美国医药统计数据，2021年美国医药产业收入达5,500亿美元，而美国人同年在药品上的支出为5,769亿美元。预计到2025年，美国的医药支出将在6,050亿美元至6,350亿美元之间。抗病毒药物的开发在治疗病毒感染方面发挥至关重要的作用，并有助于市场的整体成长。抗病毒药物的流行反映了对抗病毒感染的研究和开发的持续努力。另一方面，欧洲是第二大市场成长地区，这主要是由于传染病预防和诊断支出的增加。

传染病治疗市场-竞争格局：

每年，美国製药业都会推出各种具有显着医疗功效的新药。然而，其中相当多的药物价格昂贵，导致私营部门和联邦政府的医疗费用不断增加。为了进入市场，新兴生物製药公司（通常是新创公司或中型企业）推出了专门针对传染病或利基领域的创新疗法。相反，拥有完善研发能力的大型製药公司在传染病疗法的进步和商业化方面竞争。这些公司拥有必要的资源来进行广泛的临床试验并确保全球分销。

最近的发展：

根据资料分析和咨询公司GlobalData 的数据，辉瑞、吉利德和葛兰素史克预计到2023 年将成为传染病市场的领导者。儘管当年COVID-19 销售额预计将下降64%，但该市场预计仍将成长每年以5.7% 的速度成长，到2029 年年销售额将达到1500 亿美元。儘管全球人口大部分接种了疫苗，而且世界卫生组织宣布这场流行病结束为全球卫生紧急事件，但预计仍将出现这种增长。

目录

第一章：传染病治疗市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 依治疗方式分類的传染病治疗市场片段
    • 按传染病类型分類的传染病治疗市场片段
    • 按配销通路的传染病治疗市场片段
    • 按国家/地区分類的传染病治疗市场片段
    • 按地区分類的传染病治疗市场片段
  • 竞争洞察

第 3 章：传染病治疗主要市场趋势

  • 传染病治疗市场驱动因素
    • 市场驱动因素的影响分析
  • 传染病治疗市场限制
    • 市场限制影响分析
  • 传染病治疗市场机会
  • 传染病治疗市场未来趋势

第 4 章：传染病治疗产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：传染病治疗市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：传染病治疗市场格局

  • 2022 年传染病治疗市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：传染病治疗市场 - 依治疗模式

  • 概述
    • 按治疗方式分類的细分市场占有率分析
    • 疫苗
    • 药品

第 8 章：传染病治疗市场 - 依传染病类型

  • 概述
    • 按传染类型分類的细分市场份额分析
    • 病毒性的
    • 寄生
    • 真菌
    • 细菌
    • 其他的

第 9 章：传染病治疗市场 - 按配销通路

  • 概述
    • 按配销通路分類的细分市场份额分析
    • 诊所
    • 医院
    • 其他的

第 10 章：传染病治疗市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美传染病治疗主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模与预测（按治疗方式）
    • 北美市场规模和预测（按感染类型）
    • 北美市场规模和预测（按配销通路）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲传染病治疗主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模与预测（按治疗方式）
    • 欧洲市场规模和预测（按感染类型）
    • 欧洲市场规模和预测（按配销通路）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区传染病治疗主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（依治疗方式）
    • 亚太地区市场规模和预测（按感染类型）
    • 亚太地区市场规模和预测（按配销通路）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲传染病治疗主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按治疗方式）
    • 拉丁美洲市场规模与预测（按感染类型）
    • 拉丁美洲市场规模和预测（按配销通路）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲传染病治疗主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按治疗方式）
    • 中东和非洲市场规模及预测（按感染类型）
    • 中东和非洲市场规模及预测（按配销通路）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - 传染病治疗产业

  • 竞争仪表板
  • 公司简介
    • Pfizer Inc.
    • Novartis AG,
    • Gilead
    • GlaxoSmithKline plc
    • Janssen Pharmaceutical, Inc.
    • F. Hoffmann-La Roche Ltd.
    • BioCryst Pharmaceuticals Inc.
    • Merck & Co., Inc.
    • Boehringer Ingelheim GmbH.
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV2061

REPORT HIGHLIGHT

Infectious Disease Therapeutics Market size was valued at USD 68,034 Million in 2022, expanding at a CAGR of 8.2% from 2023 to 2030.

Infectious disease therapeutics encompasses the management of illnesses caused by harmful microorganisms including bacteria, viruses, fungi, and parasites. The primary objective of infectious disease therapeutics is to eradicate or regulate the proliferation and transmission of these pathogens within the body. The prompt identification and efficient treatment of individuals affected by infectious diseases have been among the most significant advancements in the field of medicine in the last century. Presently, cardiovascular disease and cancer have become the leading causes of mortality in the United States. However, the absence of innovative compounds and vaccines for the treatment and prevention of infectious diseases reaching clinical proof of concept in recent decades has resulted in a global health crisis. The emergence of new and previously unknown infectious diseases poses a grave threat to human well-being and the worldwide economy, as exemplified by the ongoing SARS-CoV-2 outbreak. To counteract these risks, it is imperative to implement comprehensive containment strategies, including virus characterization, serological testing, research on therapeutic antibodies, and the development of vaccines utilizing optimized protein expression systems to combat the rapid evolution of pathogens.

Infectious Disease Therapeutics Market- Market Dynamics

Increasing number of cases suffering with infectious diseases is expected to drive the growth of market

There is an increase in the number of cases of infectious diseases, it can drive the demand for therapeutic interventions. This may be due to factors such as changes in lifestyle, antibiotic resistance, international travel, and population density. Examples of infectious diseases include the flu, measles, HIV, strep throat, COVID-19, and salmonella. While infectious diseases are widespread globally, their prevalence varies. For instance, in the United States, approximately 1 out of every 5 individuals gets infected with the influenza virus each year, whereas the number of diagnosed prion diseases is less than 300. According to the National Center for health statistics, there are approximately 3.8 million emergency department visits with infectious and parasitic diseases as the primary diagnosis. However, the continuous advancements in biotechnology and pharmaceutical research offer opportunities for the development of more effective and targeted therapeutics for infectious diseases. Additionally, economic downturns and uncertainties can have an impact on healthcare budgets and the allocation of funds toward infectious disease therapeutics.

Infectious Disease Therapeutics Market- Key Insights

  • As per the analysis shared by our research analyst, the global Infectious Disease Therapeutics market is estimated to grow annually at a CAGR of around 8.2% over the forecast period (2023-2030)
  • Based on Mode of Treatment segmentation, Drugs was predicted to show maximum market share in the year 2022
  • Based on Infectious Type segmentation, Bacterial was the leading type in 2022
  • Based on Distribution Channel segmentation, Hospital was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Infectious Disease Therapeutics Market- Segmentation Analysis:

  • The Global Infectious Disease Therapeutics Market is segmented on the basis of Mode of Treatment, Infectious Type, Distribution Channel and Region.
  • The market is divided into three categories based on Mode of Treatment: Vaccines and Drugs. The drugs segment dominates the market. Numerous global health organizations, governments, and NGOs actively contribute to promoting the availability of drugs for infectious diseases, especially in regions where these diseases present substantial public health obstacles.
  • The market is divided into two categories based on Infectious Type: Viral, Parasitic, Fungal, Bacterial and Others. The dominance of the bacterial segment largely influences the market. Bacterial infections continue to pose a major public health concern, particularly in developing regions. Efforts from global health initiatives, in conjunction with partnerships between governments, non-profit organizations, and pharmaceutical companies, strive to enhance the availability of effective treatments and alleviate the global burden of bacterial infections.
  • The market is divided into two categories based on Distribution channel: Clinic, Hospitals and Others. Hospitals Segment dominates the market. The market is predominantly controlled by the Hospitals Segment. Hospitals play a vital role in the identification and treatment of infectious diseases. They possess diagnostic facilities, laboratories, and a team of medical professionals who collaborate to determine the causative agents of infections and recommend suitable therapeutic measures.

Infectious Disease Therapeutics Market- Geographical Insights

The Infectious Disease Therapeutics Market is geographically widespread across various regions including North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided based on the nations involved in the business. In terms of growth, North America is expected to dominate the market due to the increasing prevalence of antiviral drugs and the presence of numerous manufacturers in the United States. The United States serves as a hub for research and development in the healthcare and pharmaceutical sectors, with substantial investments in R&D leading to the discovery of new therapeutic agents for infectious diseases. According to U.S. Pharmaceutical Statistics, the revenue generated by the U.S. pharmaceutical industry reached USD 550 billion in 2021, while Americans spent USD 576.9 billion on medicine during the same year. It is projected that the United States will spend between USD605 billion and USD635 billion on medicine by 2025. The development of antiviral medications plays a crucial role in treating viral infections and contributes to the overall growth of the market. The prevalence of antiviral drugs reflects the ongoing efforts in research and development to combat viral infections. Europe, on the other hand, is the second-largest region for market growth, primarily due to the rising expenditure on the prevention and diagnosis of infectious diseases.

Infectious Disease Therapeutics Market- Competitive Landscape:

Every year, the pharmaceutical industry in the United States introduces a variety of new drugs that offer significant medical benefits. However, a considerable number of these drugs are costly and contribute to the increasing healthcare expenses for both the private sector and the federal government. In order to enter the market, emerging biopharmaceutical companies, often startups or medium-sized enterprises, bring forth innovative therapeutics that specifically target infectious diseases or niche areas. Conversely, large pharmaceutical companies with well-established research and development capabilities compete in the advancement and commercialization of infectious disease therapeutics. These companies possess the necessary resources to conduct extensive clinical trials and ensure global distribution.

Recent Developments:

According to data analytics and consultancy GlobalData, Pfizer, Gilead, and GSK are expected to become the leading players in the infectious diseases market by 2023. Despite a projected 64% decrease in COVID-19 sales that year, the market is anticipated to grow at a rate of 5.7% annually, reaching $150 billion in annual sales by 2029. This growth is predicted despite the global population being largely vaccinated and the World Health Organization declaring an end to the pandemic as a global health emergency.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL INFECTIOUS DISEASE THERAPEUTICS MARKET KEY PLAYERS

  • Pfizer Inc.
  • Novartis AG,
  • Gilead
  • GlaxoSmithKline plc
  • Janssen Pharmaceutical, Inc.
  • F. Hoffmann-La Roche Ltd.
  • BioCryst Pharmaceuticals Inc.
  • Merck & Co., Inc.
  • Boehringer Ingelheim GmbH.
  • Others

GLOBAL INFECTIOUS DISEASE THERAPEUTICS MARKET, BY MODE OF TREATMENT

  • Vaccines
  • Drugs

GLOBAL INFECTIOUS DISEASE THERAPEUTICS MARKET, BY INFECTIOUS TYPE

  • Viral
  • Parasitic
  • Fungal
  • Bacterial
  • Others

GLOBAL INFECTIOUS DISEASE THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL

  • Clinic
  • Hospitals
  • Others

GLOBAL INFECTIOUS DISEASE THERAPEUTICS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Infectious Disease Therapeutics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Infectious Disease Therapeutics Market Snippet by Mode of treatment
    • 2.1.2. Infectious Disease Therapeutics Market Snippet by Infectious Type
    • 2.1.3. Infectious Disease Therapeutics Market Snippet by Distribution channel
    • 2.1.4. Infectious Disease Therapeutics Market Snippet by Country
    • 2.1.5. Infectious Disease Therapeutics Market Snippet by Region
  • 2.2. Competitive Insights

3. Infectious Disease Therapeutics Key Market Trends

  • 3.1. Infectious Disease Therapeutics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Infectious Disease Therapeutics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Infectious Disease Therapeutics Market Opportunities
  • 3.4. Infectious Disease Therapeutics Market Future Trends

4. Infectious Disease Therapeutics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Infectious Disease Therapeutics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Infectious Disease Therapeutics Market Landscape

  • 6.1. Infectious Disease Therapeutics Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Infectious Disease Therapeutics Market - By Mode of treatment

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Mode of treatment, 2022 & 2030 (%)
    • 7.1.2. Vaccines
    • 7.1.3. Drugs

8. Infectious Disease Therapeutics Market - By Infectious Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Infectious Type, 2022 & 2030 (%)
    • 8.1.2. Viral
    • 8.1.3. Parasitic
    • 8.1.4. Fungal
    • 8.1.5. Bacterial
    • 8.1.6. Others

9. Infectious Disease Therapeutics Market - By Distribution channel

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Distribution channel, 2022 & 2030 (%)
    • 9.1.2. Clinic
    • 9.1.3. Hospitals
    • 9.1.4. Others

10. Infectious Disease Therapeutics Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Infectious Disease Therapeutics Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Infectious Disease Therapeutics Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Infectious Disease Therapeutics Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Infectious Disease Therapeutics Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Infectious Disease Therapeutics Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Infectious Disease Therapeutics Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Pfizer Inc.
    • 11.2.2. Novartis AG,
    • 11.2.3. Gilead
    • 11.2.4. GlaxoSmithKline plc
    • 11.2.5. Janssen Pharmaceutical, Inc.
    • 11.2.6. F. Hoffmann-La Roche Ltd.
    • 11.2.7. BioCryst Pharmaceuticals Inc.
    • 11.2.8. Merck & Co., Inc.
    • 11.2.9. Boehringer Ingelheim GmbH.
    • 11.2.10. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Infectious Disease Therapeutics Market: Mode of treatment Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Mode of treatment
  • TABLE Global Infectious Disease Therapeutics Market, by Mode of treatment 2018-2030 (USD Million)
  • TABLE Infectious Disease Therapeutics Market: Infectious Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Infectious Type
  • TABLE Global Infectious Disease Therapeutics Market, by Infectious Type 2018-2030 (USD Million)
  • TABLE Infectious Disease Therapeutics Market: Distribution channel Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Distribution channel
  • TABLE Global Infectious Disease Therapeutics Market, by Distribution channel 2018-2030 (USD Million)
  • TABLE Infectious Disease Therapeutics Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Infectious Disease Therapeutics Market, by Region 2018-2030 (USD Million)
  • TABLE North America Infectious Disease Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Infectious Disease Therapeutics Market, by Mode of treatment, 2018-2030 (USD Million)
  • TABLE North America Infectious Disease Therapeutics Market, by Infectious Type, 2018-2030 (USD Million)
  • TABLE North America Infectious Disease Therapeutics Market, by Distribution channel, 2018-2030 (USD Million)
  • TABLE Europe Infectious Disease Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Infectious Disease Therapeutics Market, by Mode of treatment, 2018-2030 (USD Million)
  • TABLE Europe Infectious Disease Therapeutics Market, by Infectious Type, 2018-2030 (USD Million)
  • TABLE Europe Infectious Disease Therapeutics Market, by Distribution channel, 2018-2030 (USD Million)
  • TABLE Asia Pacific Infectious Disease Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Infectious Disease Therapeutics Market, by Mode of treatment, 2018-2030 (USD Million)
  • TABLE Asia Pacific Infectious Disease Therapeutics Market, by Infectious Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Infectious Disease Therapeutics Market, by Distribution channel, 2018-2030 (USD Million)
  • TABLE Latin America Infectious Disease Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Infectious Disease Therapeutics Market, by Mode of treatment, 2018-2030 (USD Million)
  • TABLE Latin America Infectious Disease Therapeutics Market, by Infectious Type, 2018-2030 (USD Million)
  • TABLE Latin America Infectious Disease Therapeutics Market, by Distribution channel, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Infectious Disease Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Infectious Disease Therapeutics Market, by Mode of treatment, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Infectious Disease Therapeutics Market, by Infectious Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Infectious Disease Therapeutics Market, by Distribution channel, 2018-2030 (USD Million)

List of Figures

  • FIGURE Infectious Disease Therapeutics Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Mode of treatment segment market share analysis, 2022 & 2030
  • FIGURE Mode of treatment segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Infectious Type segment market share analysis, 2022 & 2030
  • FIGURE Infectious Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Distribution channel segment market share analysis, 2022 & 2030
  • FIGURE Distribution channel segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Infectious Disease Therapeutics Market share and leading players, 2022
  • FIGURE Europe Infectious Disease Therapeutics Market share and leading players, 2022
  • FIGURE Asia Pacific Infectious Disease Therapeutics Market share and leading players, 2022
  • FIGURE Latin America Infectious Disease Therapeutics Market share and leading players, 2022
  • FIGURE Middle East and Africa Infectious Disease Therapeutics Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Infectious Disease Therapeutics Market share analysis by country, 2022
  • FIGURE Germany Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Infectious Disease Therapeutics Market share analysis by country, 2022
  • FIGURE India Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Infectious Disease Therapeutics Market share analysis by country, 2022
  • FIGURE Brazil Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Infectious Disease Therapeutics Market share analysis by country, 2022
  • FIGURE Saudi Arabia Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)